2,914 material Form 8-K filings that 2,352 companies we cover made with the SEC in August 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Flexsteel reported fourth quarter and fiscal 2026 results on August 17, 2026. Q4 net sales rose 0.7% to $115.4 million and GAAP diluted EPS was $2.58 versus $1.89, helped by a $9.0 million tariff refund that the company excludes from its adjusted figures. Adjusted diluted EPS fell to $1.33 from $1.40, and the company guided first-quarter fiscal 2027 sales of $111 million to $115 million.
Q4 net sales were $115.4 million, up from $114.6 million; the CEO called it the eleventh consecutive quarter of year-over-year growth.
Q4 GAAP diluted EPS was $2.58 versus $1.89; adjusted diluted EPS was $1.33 versus $1.40.
Fiscal 2026 net sales rose 4.1% to $459.2 million; GAAP diluted EPS was $6.07 versus $3.55.
First-quarter fiscal 2027 outlook: sales growth of 1% to 4%, GAAP operating margin of 6.5% to 7%; conference call on August 18, 2026 at 8:00 a.m. Central Time.
Limoneira subsidiary Windfall Investors agreed on August 15, 2026 to sell five Paso Robles, California vineyard properties of about 724 acres to Paul Rusnak for $15 million, following a public auction. The company also expects an additional impairment charge of about $4.1 million, bringing the total impairment to about $13.4 million, which the company links to the sale and to a previously terminated sale.
Purchase price is $15 million; buyer must post a 12% nonrefundable earnest money deposit
Closing is scheduled no later than September 14, 2026 (the press release says September 15); the deal is not conditioned on financing
Additional impairment of about $4.1 million expected in Q4 fiscal 2026, on top of about $9.3 million previously estimated for Q2, for about $13.4 million total
Seller keeps the 2026 harvest and access to farm through November 30, 2026; CEO Harold Edwards said proceeds will reduce debt and fund avocado acreage expansion
Vuzix reported second-quarter 2026 results for the three months ended June 30, 2026, in a press release dated August 13, 2026. Total sales fell 14% to $1.1 million from $1.3 million, while the net loss was $7.7 million, or $0.09 per share, compared with $0.10 per share a year earlier. The company had $17.3 million in cash and no debt at June 30, 2026, but operating cash use rose to $6.6 million from $4.8 million.
Total sales were $1.1 million versus $1.3 million, a 14% decline; product sales fell 15% to $0.9 million.
Net loss was $7.7 million, or $0.09 per share, compared with a loss of $7.7 million, or $0.10 per share, in the second quarter of 2025.
Research and development expense rose 20% to $3.1 million, while the gross loss narrowed to $0.6 million from $0.8 million.
Net cash used in operating activities was $6.6 million, up from $4.8 million; cash totaled $17.3 million with no current or long-term debt.
Permianville Royalty Trust announced a cash distribution of $0.027000 per unit, payable September 15, 2026, to unitholders of record on August 31, 2026. Oil cash receipts rose $0.1 million to $3.3 million, while natural gas receipts fell $0.4 million to $1.1 million, and the Sponsor kept a $2.0 million reserve for future development expenses, which could be released later if unspent.
Distribution of $0.027000 per unit, payable September 15, 2026, record date August 31, 2026
Oil cash receipts $3.3 million, up $0.1 million from the prior month, at $95.23 per barrel
Natural gas cash receipts $1.1 million, down $0.4 million from the prior month, at $2.37 per Mcf
Sponsor COERT Holdings 1 LLC maintains a $2.0 million reserve for approved future development expenses
20/20 BioLabs reported second-quarter 2026 revenue of $0.7 million, up 36.5% from the prior year, and gross margin of 41.7%, up from 30.5%. Net loss widened to $1.5 million from $0.8 million, which the filing attributes partly to one-time Nasdaq listing costs and about $0.7 million in non-cash charges, and the company ended the quarter with $4.5 million in cash and no convertible note debt.
Q2 2026 revenue was $0.7 million, up 36.5% from $0.5 million; OneTest revenue rose 47.1% to $0.7 million.
Gross margin was 41.7% in Q2 2026, compared with 30.5% a year earlier.
Operating expenses rose to $1.5 million from $1.0 million, mainly from Nasdaq direct listing costs and product development.
Net loss was $1.5 million, versus $0.8 million, and cash and cash equivalents were $4.5 million as of June 30, 2026.
ENDRA reported net income of $159,944 for the quarter ended June 30, 2026, compared with a net loss of $1,225,912 a year earlier. The result came from $1.6 million in other income, mainly digital asset gains, while total operating expenses rose to $1.5 million from $1.3 million. The company is pursuing a merger with Noble Africa LLC, which is expected to close in the fourth quarter of 2026 and would rename ENDRA Noble Africa Inc.
Q2 2026 net income was $159,944, versus a net loss of $1,225,912 in Q2 2025.
Total operating expenses were $1,483,256, up from $1,301,090; other income was $1.6 million, mainly from digital asset gains.
As of June 30, 2026, cash was $1,739,943 and restricted cash was $3,800,003.
Merger agreement with Noble Africa dated June 25, 2026; closing expected in Q4 2026, subject to stockholder and regulatory approvals.
NVIDIA entered multiple residual value guaranties with SB Energy covering leases for about 4.25 gigawatts of IT load at the PORTS-Pike campus in Pike County, Ohio, with OpenAI as tenant. NVIDIA's aggregate payment obligation for its initial commitment is capped at $105 billion, and it can provide additional credit support for about 3.8 gigawatts more at its discretion. The commitment is large and long-dated, and NVIDIA would pay if OpenAI defaults on a lease, though OpenAI has agreed to reimburse amounts NVIDIA pays.
Guaranties cover leases for about 4.25 gigawatts of IT load; NVIDIA's initial payment obligation is capped at $105 billion.
Payments are subject to conditions, including ready-for-service conditions under the leases, expected beginning in 2028.
A payment is triggered if OpenAI becomes insolvent or fails to make lease payments; OpenAI must reimburse NVIDIA for amounts paid.
NVIDIA will invest $1.5 billion in SB Energy, according to the attached press release.
INVO Fertility reported second-quarter 2026 revenue of $2,175,485, up 17% from $1,863,654 a year earlier, mainly due to the February 2026 Family Beginnings acquisition. The company swung to net income of $888,740 from a net loss of $3,618,969, but that result includes an approximately $2.5 million remeasurement gain tied to the Birmingham clinic acquisition, while Adjusted EBITDA was a loss of $1,032,660 versus $587,229 a year earlier.
Q2 2026 revenue was $2,175,485 versus $1,863,654 in Q2 2025, an increase of 17%.
Net income was $888,740 versus a net loss of $3,618,969, including an approximately $2.5 million gain on remeasurement related to the Birmingham acquisition.
Adjusted EBITDA was $(1,032,660) versus $(587,229) in Q2 2025.
On August 16, 2026, Dermata Therapeutics agreed to sell 933,064 common shares and pre-funded warrants for 1,360,544 shares in a private placement, with accompanying series E and F warrants. The company expects gross proceeds of about $3.4 million and net proceeds of about $3.2 million, and up to about $6.7 million more if the warrants are exercised in full, though exercise is not assured. The new shares and warrants could dilute existing shareholders, and company insiders, including the CEO and CFO, participated in the offering.
Private placement priced at $1.46 per share and accompanying warrants; insiders paid $1.47 per share
Expected gross proceeds of about $3.4 million, net proceeds of about $3.2 million; closing expected on or about August 18, 2026
Warrants could add up to about $6.7 million if exercised in full; warrants become exercisable only after stockholder approval
Company must file a resale registration statement within 60 days of the August 16, 2026 registration rights agreement
Fulcrum Therapeutics signed a merger agreement on August 16, 2026, under which Slate Medicines will combine with Fulcrum in an all-stock deal, with the combined company to be renamed Slate Medicines. Fulcrum expects to pay its pre-merger stockholders a cash dividend of $270 million, but those holders are expected to own only about 5.0% of the combined company, subject to adjustment based on Fulcrum's net cash at closing.
Pre-merger Fulcrum stockholders are expected to own about 5.0% of the combined company on a fully diluted basis.
Fulcrum expects to declare a cash dividend of $270 million to its pre-merger stockholders in connection with the closing.
A concurrent private placement of approximately $245.0 million is a closing condition, and the closing is expected in the fourth quarter of 2026.
Termination fees are $10 million payable by Fulcrum and $15 million payable by Slate in certain circumstances.
L3Harris appointed Sam Mehta, its President of the Space & Mission Systems and Communications & Spectrum Dominance segments, as President and CEO effective immediately, and he joined the Board. Chairman and CEO Christopher Kubasik left the company after a board investigation found conduct inconsistent with the company's Code of Conduct, which the company said had no impact on financial reporting, controls, customer relationships or operations. The company also reaffirmed its 2026 guidance for consolidated revenue, organic growth, segment operating margin, GAAP earnings per share and free cash flow.
Sam Mehta named President and CEO effective August 17, 2026, with an annual base salary of $1,250,000, a 200% target annual cash bonus and a long-term incentive target of $13,250,000, prorated for 2026
Christopher Kubasik ended his employment as Chairman and CEO effective August 17, 2026, and resigned from the Board; he receives no severance or accelerated vesting of unvested equity
Lewis Hay III named Independent Chairman of the Board; Lauren Barnes appointed President of Space & Mission Systems and Christopher Aebli President of Communications & Spectrum Dominance
L3Harris reaffirmed 2026 guidance for consolidated revenue, organic growth, segment operating margin, GAAP earnings per share and free cash flow
AmpliTech amended its Asset Purchase Agreement with Titan Crest, reducing the aggregate purchase price from $8 million to $7 million, and said it did not waive rights or claims against Titan. The company expects full-year 2026 revenue to exceed FY2025 revenue, but it declined to give a more precise estimate because certain Asian customers shifted deployment schedules, which affects shipment and revenue timing.
Amendment No. 2 reduced the aggregate APA purchase price by $1 million, from $8 million to $7 million; the company says rights and claims remain intact.
Expects 2026 revenue to exceed FY2025 revenue; certain Asian customers shifted deployment schedules, though orders have not been cancelled.
Approximately $17 million in current order backlog, and more than $17 million in 5G ORAN shipments completed since program inception.
Expects positive EBITDA in fiscal 2027 and improved ORAN margins beginning in 2027, after an initial program that accepted approximately $2 million in reduced profit.
Prairie Operating Co. reported second-quarter 2026 revenue of $98.9 million, up about 45% from a year earlier, and net income attributable to common stockholders of $193.8 million, or $0.23 diluted EPS. Adjusted EBITDA was $34.0 million, down from $38.6 million a year earlier, and the company also amended its credit facility on August 14, 2026 and adjusted its full-year 2026 guidance, so shareholders face mixed signals on operating profit and balance-sheet changes.
Q2 2026 revenue of $98.9 million versus $68.1 million in Q2 2025; adjusted EBITDA of $34.0 million versus $38.6 million
Q2 net income to common stockholders of $193.8 million was helped by non-cash items, including a $48.2 million fair value gain and a $45.1 million derivative gain
Six-month 2026 net loss attributable to Prairie of $43.7 million; diluted EPS of $(0.41)
Full-year 2026 adjusted EBITDA guidance of $180.0 million to $190.0 million; credit facility amendment dated August 14, 2026
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.